Publications by authors named "Alina Morosanu"
Article Synopsis
- Ixekizumab is a biologic treatment targeting the IL-17 pathway, used for conditions like psoriasis and ankylosing spondylitis, alongside Secukinumab and Brodalumab.
- A case study is presented about a 42-year-old woman who developed severe complications, including bloody diarrhea and fever, just one week after starting Ixekizumab for psoriasis and psoriatic arthritis.
- Despite attempts at medical treatment, her condition worsened to require emergency colectomy, suggesting that Ixekizumab may be linked to the onset of inflammatory bowel disease.
The purpose of this study is to analyse the trends manifested in research literature from the field of healthcare management, with emphasis on bibliometric features and different influencing factors. For this, a search was conducted of nine academic databases between January and May 2021. Article features were registered in our database after first applying the validation criteria used for their inclusion.
View Article and Find Full Text PDF